Skip to main content
Top
Published in: AIDS Research and Therapy 1/2018

Open Access 01-12-2018 | Research

Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital

Authors: Sosthene Tsongo Vululi, Samuel Bugeza, Muyinda Zeridah, Henry Ddungu, Akello Betty Openy, Mubiru Frank, Rosalind Parkes-Ratanshi

Published in: AIDS Research and Therapy | Issue 1/2018

Login to get access

Abstract

Background

Deep venous thrombosis (DVT) and its major complication pulmonary embolism (PE) are collectively known as venous thromboembolism. In Uganda, the prevalence of DVT among HIV patients has not been previously published. The aim of the study was to determine the prevalence and sonographic features of lower limb deep venous thrombosis among HIV positive patients on anti-retroviral treatment (ART).

Methods

This was a cross sectional study in which HIV positive patients on ART were recruited from an out-patient HIV clinic at Mulago National Referral Hospital. Patients were randomly selected and enrolled until a sample size of 384 was reached. Study participants underwent compression and Doppler ultrasound studies of both lower limb deep veins using Medison Sonoacer7 ultrasound machine.

Resuts

We found a prevalence of DVT of 9.1% (35 of 384 participants) among HIV patients on ART. The prevalence of latent (asymptomatic) DVT was 2.3%. Among 35 patients with DVT, 42.8% had chronic DVT; 31.1% had acute DVT and the rest had latent DVT. Among the risk factors, the odds of occurrence of DVT among patients with prolonged immobility were 4.81 times as high as in those with no prolonged immobility (p = 0.023; OR = 4.81; 95% CI 1.25–18.62). Treatment with second line anti-retroviral therapy (ART) including protease inhibitors (PIs) was associated with higher odds of DVT occurrence compared with first line ART (p = 0.020; OR = 2.38; 95% CI 1.14–4.97). The odds of DVT occurrence in patients with a lower CD4 count (< 200 cells/µl) were 5.36 times as high as in patients with CD4 counts above 500 cells/µl (p = 0.008). About 48.6% patients with DVT had a low risk according to Well’s score.

Conclusion

DVT was shown in nearly 10% of HIV patients attending an out-patient clinic in an urban setting in Uganda. Risk factors included protease inhibitors in their ART regimen, prolonged immobility, and low CD4 count (< 200 cells/µl). Clinicians should have a low threshold for performing lower limb Doppler ultrasound scan examination on infected HIV patients on ART who are symptomatic for DVT. Therefore, clinicians should consider anti-coagulant prophylaxis and lower deep venous ultrasound screening of patients who are on second line ART regimen with low CD4 cell counts and/or with prolonged immobility or hormonal contraception.
Literature
1.
go back to reference Malani PN. Harrison’s principles of internal medicine. JAMA. 2012;308(17):1813–4.CrossRef Malani PN. Harrison’s principles of internal medicine. JAMA. 2012;308(17):1813–4.CrossRef
2.
go back to reference Louw S, Jacobson BF, Büller H. Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost. 2008;14(3):352–5.CrossRefPubMed Louw S, Jacobson BF, Büller H. Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost. 2008;14(3):352–5.CrossRefPubMed
3.
go back to reference Eyal A, Veller M. HIV and venous thrombotic events: vascular surgery: review. S Afr J Surg. 2009;47(2):54–6.PubMed Eyal A, Veller M. HIV and venous thrombotic events: vascular surgery: review. S Afr J Surg. 2009;47(2):54–6.PubMed
5.
go back to reference Veller M, Pillai J. Lower-limb venous thrombosis. Contin Med Educ. 2009;27(7):306–11. Veller M, Pillai J. Lower-limb venous thrombosis. Contin Med Educ. 2009;27(7):306–11.
6.
go back to reference Crum-Cianflone NF, Weekes J, Bavaro M. Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDs. 2008;22(10):771–8.CrossRefPubMedPubMedCentral Crum-Cianflone NF, Weekes J, Bavaro M. Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDs. 2008;22(10):771–8.CrossRefPubMedPubMedCentral
7.
go back to reference Mangeni F, Kawooya M, Kiguli-Malwadde E, Ssali F. Sonography and risk factors for lower limb deep venous thrombosis at Mulago hospital, Uganda. East Afr Med J. 2006;83(8):443–9.CrossRefPubMed Mangeni F, Kawooya M, Kiguli-Malwadde E, Ssali F. Sonography and risk factors for lower limb deep venous thrombosis at Mulago hospital, Uganda. East Afr Med J. 2006;83(8):443–9.CrossRefPubMed
8.
go back to reference Gordis Leon. Epidemiology. 3rd ed. Philadelphia: Elsevier; 2004. Gordis Leon. Epidemiology. 3rd ed. Philadelphia: Elsevier; 2004.
9.
go back to reference Geerts W, Cook D, Selby R, Etchells E. Venous thromboembolism and its prevention in critical care. J Crit Care. 2002;17(2):95–104.CrossRefPubMed Geerts W, Cook D, Selby R, Etchells E. Venous thromboembolism and its prevention in critical care. J Crit Care. 2002;17(2):95–104.CrossRefPubMed
11.
go back to reference Saif M. Thromboembolism associated with HIV infection: a case report and review of the literature. AIDS Reader. 2000;10(8):492–6.PubMed Saif M. Thromboembolism associated with HIV infection: a case report and review of the literature. AIDS Reader. 2000;10(8):492–6.PubMed
12.
go back to reference Friedman AC. Diagnostic ultrasound, vols. 1 and 2. Am J Roentgenol. 2006;187(1):W139.CrossRef Friedman AC. Diagnostic ultrasound, vols. 1 and 2. Am J Roentgenol. 2006;187(1):W139.CrossRef
13.
go back to reference Chaer RA, et al. Multimodal therapy for acute and chronic venous thrombotic and occlusive disease. Vasc Endovasc Surg. 2005;39(5):375–80.CrossRef Chaer RA, et al. Multimodal therapy for acute and chronic venous thrombotic and occlusive disease. Vasc Endovasc Surg. 2005;39(5):375–80.CrossRef
14.
go back to reference Khaladkar SM, Thakkar DK, et al. Deep vein thrombosis of the lower limbs: a retrospective analysis of doppler ultrasound findings. Med J Dr DY Patil Univ. 2014;7(5):612.CrossRef Khaladkar SM, Thakkar DK, et al. Deep vein thrombosis of the lower limbs: a retrospective analysis of doppler ultrasound findings. Med J Dr DY Patil Univ. 2014;7(5):612.CrossRef
15.
go back to reference De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. Aids. 2012;26(10):1205–13.CrossRefPubMed De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. Aids. 2012;26(10):1205–13.CrossRefPubMed
16.
go back to reference Shen Y, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004;10(3):277–80.CrossRefPubMed Shen Y, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004;10(3):277–80.CrossRefPubMed
17.
go back to reference Aldington S, Pritchard A, Perrin K, James K, Wijesinghe M, Beasley R. Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission. Intern Med J. 2008;38(2):133–5.CrossRefPubMed Aldington S, Pritchard A, Perrin K, James K, Wijesinghe M, Beasley R. Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission. Intern Med J. 2008;38(2):133–5.CrossRefPubMed
19.
go back to reference Rocha AT, et al. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16(12):1645–55.CrossRefPubMed Rocha AT, et al. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16(12):1645–55.CrossRefPubMed
20.
go back to reference Leibson CL, Petterson TM, Bailey KR, Melton LJ, Heit JA. Risk factors for venous thromboembolism in nursing home residents. In: Mayo clinic proceedings vol. 83, no. 2. New York: Elsevier; 2008. p. 151–7. Leibson CL, Petterson TM, Bailey KR, Melton LJ, Heit JA. Risk factors for venous thromboembolism in nursing home residents. In: Mayo clinic proceedings vol. 83, no. 2. New York: Elsevier; 2008. p. 151–7.
21.
go back to reference Zarowitz BJ, et al. Thrombotic risk and immobility in residents of long-term care facilities. J Am Med Direct Assoc. 2010;11(3):211–21.CrossRef Zarowitz BJ, et al. Thrombotic risk and immobility in residents of long-term care facilities. J Am Med Direct Assoc. 2010;11(3):211–21.CrossRef
22.
go back to reference Klein SK, Slim EJ, De Kruif MD, Keller TT, Ten Cate H, van Gorp EC, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63(4):129–36.PubMed Klein SK, Slim EJ, De Kruif MD, Keller TT, Ten Cate H, van Gorp EC, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63(4):129–36.PubMed
23.
go back to reference Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV-infected individuals. Aids. 2000;14(3):321–4.CrossRefPubMed Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV-infected individuals. Aids. 2000;14(3):321–4.CrossRefPubMed
24.
25.
go back to reference Levine AM, et al. Progressive prothrombotic state in women with advancing HIV disease. JAIDS J Acquir Immune Defic Syndr. 2006;42(5):572–7.CrossRefPubMed Levine AM, et al. Progressive prothrombotic state in women with advancing HIV disease. JAIDS J Acquir Immune Defic Syndr. 2006;42(5):572–7.CrossRefPubMed
Metadata
Title
Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital
Authors
Sosthene Tsongo Vululi
Samuel Bugeza
Muyinda Zeridah
Henry Ddungu
Akello Betty Openy
Mubiru Frank
Rosalind Parkes-Ratanshi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2018
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-018-0191-1

Other articles of this Issue 1/2018

AIDS Research and Therapy 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine